Cabaletta Bio (CABA) Cash from Financing Activities (2018 - 2025)

Cabaletta Bio's Cash from Financing Activities history runs 8 years deep, the most recent figure standing at $8.3 million for Q4 2025.

• In Q4 2025, Cash from Financing Activities rose 90.58% year-over-year to $8.3 million; the TTM figure through Dec 2025 stood at $100.3 million (up 759.36% YoY), while the FY2025 annual figure was $100.3 million, up 759.36% from the prior year.
• Cash from Financing Activities for Q4 2025 stood at $8.3 million, up from -$806000.0 in the prior quarter.
• The five-year high for Cash from Financing Activities was $94.3 million in Q2 2023, with the low at -$806000.0 in Q3 2025.
• The 5-year median for Cash from Financing Activities is $4.4 million (2024), against an average of $20.1 million.
• The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities jumped 235545.0% in 2023, then sank 1235.21% in 2025.
• Cabaletta Bio's Cash from Financing Activities stood at $13.6 million in 2021, then surged by 141.35% to $32.9 million in 2022, then soared by 182.9% to $93.0 million in 2023, then plunged by 95.3% to $4.4 million in 2024, then surged by 90.58% to $8.3 million in 2025.
• Business Quant data shows CABA's Cash from Financing Activities at $8.3 million in Q4 2025, -$806000.0 in Q3 2025, and $93.4 million in Q2 2025.